// App-Quantinova.ai

[SAT0286] : MONTHLY IBANDRONATE REDUCES BONE LOSS IN OSTEOPENIC WOMEN WITH RHEUMATOID ARTHRITIS RECEIVING LONG-TERM GLUCOCORTICOIDS: A 48-WEEK DOUBLE-BLINDED RANDOMIZED PLACEBO-CONTROLLED INVESTIGATOR-INITIATED TRIAL

Researchers

Presenter

  • K. Shin

Principal Investigators

  • S.H. Park

  • W. Park

  • D.H. Yoo

  • Y.W. Song

  • H.J. Baek

  • Y.J. Lee

  • S.W. Kang

  • J.Y. Choe

  • W.H. Yoo

  • Y.B. Park

  • J.S. Song

  • B. Yoo

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

  • Osteoporosis

  • Inflammatory Arthritis

Biomarkers

  • Circulating tumor cells

  • Albumin/creatinine

Drug/Treatment

  • cholecalciferol

  • Glucocorticoid

  • Prednisolone

  • Ibandronic acid

  • MK8970

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved